Liu Zhiyong, Mobley James A, DeLucas Lawrence J, Kahn Richard A, West Andrew B
*Center for Neurodegeneration and Experimental Therapeutics, Department of Neurology, Center for Structural Biology, Department of Optometry, and Department of Surgery, The University of Alabama at Birmingham, Birmingham, Alabama, USA; and Department of Biochemistry, Emory University School of Medicine, Atlanta, Georgia, USA.
*Center for Neurodegeneration and Experimental Therapeutics, Department of Neurology, Center for Structural Biology, Department of Optometry, and Department of Surgery, The University of Alabama at Birmingham, Birmingham, Alabama, USA; and Department of Biochemistry, Emory University School of Medicine, Atlanta, Georgia, USA
FASEB J. 2016 Jan;30(1):336-47. doi: 10.1096/fj.15-277095. Epub 2015 Sep 22.
The leucine-rich repeat kinase (LRRK)-2 protein contains nonoverlapping GTPase and kinase domains, and mutation in either domain can cause Parkinson disease. GTPase proteins are critical upstream modulators of many effector protein kinases. In LRRK2, this paradigm may be reversed, as the kinase domain phosphorylates its own GTPase domain. In this study, we found that the ameba LRRK2 ortholog ROCO4 phosphorylates the GTPase domain [termed Ras-of-complex (ROC) domain in this family] of human LRRK2 on the same residues as the human LRRK2 kinase. Phosphorylation of ROC enhances its rate of GTP hydrolysis [from kcat (catalytic constant) 0.007 to 0.016 min(-1)], without affecting GTP or GDP dissociation kinetics [koff = 0.093 and 0.148 min(-1) for GTP and GDP, respectively). Phosphorylation also promotes the formation of ROC dimers, although GTPase activity appears to be equivalent between purified dimers and monomers. Modeling experiments show that phosphorylation induces conformational changes at the critical p-loop structure. Finally, ROC appears to be one of many GTPases phosphorylated in p-loop residues, as revealed by alignment of LRRK2 autophosphorylation sites with GTPases annotated in the phosphoproteome database. These results provide an example of a novel mechanism for kinase-mediated control of GTPase activity.
富含亮氨酸重复序列激酶(LRRK)-2蛋白包含不重叠的GTP酶和激酶结构域,任一结构域发生突变都可导致帕金森病。GTP酶蛋白是许多效应蛋白激酶的关键上游调节因子。在LRRK2中,这种模式可能会颠倒,因为激酶结构域可磷酸化其自身的GTP酶结构域。在本研究中,我们发现变形虫LRRK2直系同源物ROCO4在与人类LRRK2激酶相同的残基上磷酸化人类LRRK2的GTP酶结构域(在该家族中称为复合物Ras结构域)。ROC的磷酸化提高了其GTP水解速率[催化常数(kcat)从0.007提高到0.016 min⁻¹],而不影响GTP或GDP的解离动力学[GTP和GDP的解离常数(koff)分别为0.093和0.148 min⁻¹]。磷酸化还促进了ROC二聚体的形成,尽管纯化的二聚体和单体之间的GTP酶活性似乎相当。建模实验表明,磷酸化在关键的p环结构处诱导构象变化。最后,正如LRRK2自身磷酸化位点与磷酸化蛋白质组数据库中注释的GTP酶的比对所显示的,ROC似乎是在p环残基处被磷酸化的众多GTP酶之一。这些结果提供了一个激酶介导的GTP酶活性控制新机制的实例。